A carregar...
P08.44 Phase II study of hypofractionated radiation therapy with concomitant and adjuvant temozolomide following surgical resection for patients with newly diagnosed glioblastoma: preliminary evaluation
INTRODUCTION: The current standard treatment for glioblastoma multiforme (GBM) has led a median, overall survival (OS) of 14.6 months, a 2-year progression-free survival (PFS) of 11% and a 2-year OS of 27.2%. The predominantly local failure pattern indicates the need to intensify local treatment. Ra...
Na minha lista:
| Publicado no: | Neuro Oncol |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5782673/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/now188.177 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|